Licensed Practical Nurse in Chantilly, VA Accepting Medicare

9 Licensed Practical Nurse nurses found. Showing 1 - 9

Subiatu Salmata Wurie, L.P.N. Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4213 Walney Rd, Chantilly, VA 20151 Phone: 703-502-7000    Fax: 703-502-7006

Charese Nesbitt, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 14121 Parke Long Ct Ste 201, Chantilly, VA 20151 Phone: 855-247-1940

Shinette Amoh, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4213 Walney Rd, Chantilly, VA 20151 Phone: 703-502-7037

Dena Taylor, RN, MSN, CPNP Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3914 Centreville Rd, Chantilly, VA 20151 Phone: 703-481-8615    Fax: 703-481-8615

Alisse Nasser, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 14554 Lee Rd, Chantilly, VA 20151 Phone: 804-215-3940

Si Chen, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 14150 Parkeast Cir Ste 200, Chantilly, VA 20151 Phone: 703-968-4000

Mrs. Kelley Bryan, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 14121 Parke Long Ct, Chantilly, VA 20151 Phone: 904-521-4629

Tsgie Kidanemariam Hailu, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4213 Walney Rd, Chantilly, VA 20151 Phone: 703-502-7000

Princess Armstead, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 14554 Lee Rd, Chantilly, VA 20151 Phone: 804-215-3940

News Archive

Study provides the first detailed description of errors by hospital staff nurses

A University of Pennsylvania School of Nursing study provides the first detailed description of the nature and prevalence of errors by hospital staff nurses.

Alexza plans to reacquire U.S. rights for ADASUVE (loxapine) inhalation powder from Teva

Alexza Pharmaceuticals, Inc. announced today that it plans to reacquire the U.S. rights for ADASUVE (loxapine) inhalation powder from Teva Pharmaceuticals USA, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd., with an estimated target completion date of January 1, 2016.

New inexpensive technology can effectively sterilise medical implants

International researchers led by the University of Bath have demonstrated a cheap, effective and environmentally-friendly way to sterilise medical implants without changing their properties, in contrast to some techniques.

New targets for Leishmaniasis

A comparison of three parasite species that cause Leishmaniasis has identified a small number of genes, many new to biology, that will provide a framework to target the search for new treatments.

NYU PRC receives $3.2M award to establish Comparative Effectiveness Research Program

The NYU Health Promotion and Prevention Research Center at the NYU School of Medicine announced it has received a $3.2 million award from the Centers for Disease Control and Prevention to establish a Comparative Effectiveness Research Program focused on hypertension and colorectal cancer health disparities in African-American men in New York City.

Read more Medical News

› Verified 3 days ago